What is Cardio Genetics Testing?

Helping Pharma companies develop Precision medicine using Clinical Data & AI.

What is Cardio Genetics Testing?

Cardiovascular diseases (CVDs) remain one of the leading causes of morbidity and mortality worldwide, with genetics being a major risk factor. CVDs can arise from monogenic inherited patterns (autosomal dominant, recessive, or X-linked) or polygenic inheritance, where common genetic variants predispose individuals. GeneHealth’s testing enables precision medicine by tailoring prevention and treatment based on this genetic risk alongside lifestyle and clinical data.

Book a Test Now →

Common Inherited Monogenic Heart Diseases

Conditions Details Examples
Cardiomyopathies Diseases of the heart muscle characterized by the muscle becoming enlarged, abnormally thick, or rigid. This may result in shortness of breath, arrhythmias, or sudden death. Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular dysplasia (ARVD), Dilated cardiomyopathy (DCM), Left ventricular non-compaction (LVNC), Restrictive cardiomyopathy (RCM).
Inherited Arrhythmia Develops as a result of mutations in genes encoding ion channel proteins, involved in cardiac conduction, impairing channel function. Significant variants contribute to increased risk of ventricular arrhythmia and sudden death. Brugada syndrome (BS), Timothy syndrome (TS), Long QT syndrome (LQTS), Short QT syndrome (SQTS), Atrial fibrillation (AF), Catecholaminergic polymorphic ventricular tachycardia (CPVT).
Hypercholesterolemia & Dyslipidemia Caused by genetic variants in lipid metabolism genes resulting in high levels of LDL cholesterol. Deposition in the arteries leads to atherosclerosis and increased risk for coronary heart disease. Familial hypercholesterolemia (FH), Dysbetalipoproteinemia, Lysosomal acid lipase deficiency, Familial chylomicronemia syndrome, Sitosterolemia.
Aortopathy & Congenital Heart Disease Aneurysms involving the aortic root and/or ascending aorta without concomitant aortic valve disease. Usually progressive and the individual may be asymptomatic, diagnosed during imaging studies. Familial thoracic aortic aneurysms and dissections, Loeys-Dietz syndrome, Marfan syndrome, Ehlers-Danlos syndrome.

Indications for Testing

  • Cardiac arrest or sudden deaths in the family of unknown etiology.
  • Enlarged heart or aorta, or aortic aneurysm in the chest at less than 55 years of age.
  • Heart attack/stroke at less than 55 years of age.
  • Unexplained irregular heartbeat (arrhythmia).
  • Very high cholesterol levels.
  • Pulmonary hypertension.
  • Family history with symptoms of heart ailments.

Assay Specifications

Next Generation Sequencing: Using genomic DNA extracted from blood, the coding regions of all the genes are captured and sequenced simultaneously by NGS technology on an Illumina platform.
Multiplex Ligation Dependent Probe Amplification: This method allows for the amplification of multiple targets with only a single primer pair.
Fragment Analysis PCR: These rely on detection of changes in the length of a specific DNA sequence to indicate the presence of repeat expansions.
Sample Type: Direct DNA, Peripheral blood in EDTA.

Key Highlights of GeneHealth’s Cardio Genetics

High Sensitivity & Specificity

Ensures highly reliable and clinically actionable results of genetic testing for a multitude of inherited heart diseases.

Comprehensive Genetic Analysis

Covers a wide range of genes intricately associated with heart conditions through a comprehensive and targeted gene panel.

Advanced Methodologies

This genetic testing utilizes robust technologies including NGS, MLPA, and Fragment Analysis to perform precise genomic profiling.

wpChatIcon
error: DNS Global Made it protected !!
0

Subtotal